SuncicaVolkovMD
Rheumatology • Los Angeles, CAAssociate Professor of Medicine, University of Illinois College of Medicine
Dr. Volkov is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
200 UCLA Medical Plz Ste 365b
Los Angeles, CA 90095Phone+1 310-825-2448Fax+1 312-413-7835
Summary
- Dr. Suncica Volkov is a rheumatologist currently practicing in Chicago, IL. She completed a residency in Internal Medicine at Louis A Weiss Memorial Hospital (2000 - 2003) and a Fellowship in Rheumatology at the University of Chicago (2004 - 2006). She is a graduate from the University of Belgrade Faculty of Medicine. Dr. Volkov has multiple publications to her credit in various recognized journals covering different aspects of rheumatology, some of which have been cited multiple times. In recognition of her contribution, she has been honored as a Fellow from the American College of Rheumatology.
Education & Training
University of ChicagoFellowship, Rheumatology, 2004 - 2006
Louis A Weiss Memorial HospitalResidency, Internal Medicine, 2000 - 2003
University of Belgrade Faculty of MedicineClass of 1992
Certifications & Licensure
FL State Medical License 2022 - 2026
IL State Medical License 2000 - 2026
CA State Medical License 2021 - 2025
NE State Medical License 2019 - 2021
AZ State Medical License 2003 - 2010- American Board of Internal Medicine Rheumatology
Awards, Honors, & Recognition
- Fellow American College of Rheumatology
Publications & Presentations
PubMed
- 298 citationsOxidized LDL: Diversity, Patterns of Recognition, and PathophysiologyIrena Levitan, Suncica Volkov, Papasani V. Subbaiah
Antioxidants & Redox Signaling. 2010-07-01 - 498 citationsMycophenolate mofetil versus oral cyclophosphamide in scleroderma-related interstitial lung disease (SLS II): a randomised controlled, double-blind, parallel group trialDonald P. Tashkin, Michael D. Roth, Philip J. Clements, Daniel E. Furst, Dinesh Khanna
The Lancet. Respiratory Medicine. 2016-09-01 - 67 citationsCCL21/CCR7 signaling in macrophages promotes joint inflammation and Th17-mediated osteoclast formation in rheumatoid arthritis.Katrien Van Raemdonck, Sadiq Umar, Karol Palasiewicz, Suncica Volkov, Michael V. Volin
Cellular and Molecular Life Sciences. 2020-04-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
